Firefly Neuroscience (AIFF) vs Aether (ATHR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Firefly Neuroscience (AIFF) has outperformed Aether (ATHR) over the past year, losing 52.5% versus a loss of 84.5%. Firefly Neuroscience is the larger company by market cap ($11.8 million vs $10.5 million), about 1.1 times the size. Aether converts more of its revenue into profit, with a net margin of -227.5% versus -1741.0%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AIFF | ATHR |
|---|---|---|
| Share price | $0.75 | $0.8592 |
| Market cap | $11.81M | $10.51M |
| 1-day change | -9.64% | -34.41% |
| YTD return | -14.77% | -86.14% |
| 1-year return | -52.53% | -84.55% |
| 5-year return | -99.16% | — |
| EPS (TTM) | $-0.45 | $-0.43 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $1.14M | $1.38M |
| Revenue growth (YoY) | +957.41% | -4.11% |
| Net income (latest FY) | $-19.88M | $-3.14M |
| Gross margin | 56.48% | 70.79% |
| Operating margin | -775.48% | — |
| Net margin | -1740.98% | -227.49% |
| 52-week high | $3.15 | $6.86 |
| 52-week low | $0.62 | $0.858 |
| Distance from 52-week high | -76.19% | -87.48% |
| Analyst consensus | — | strong_buy |
| Avg. price target upside | — | +947.49% |
| Average volume | 2.66M | 12.29K |
| Shares outstanding | 15.75M | 12.24M |
| Employees | 17 | 7 |
| Sector | Technology | Technology |
| Industry | Computer Software: Prepackaged Software | Computer Software: Prepackaged Software |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- AIFF has outperformed ATHR by 32.0 percentage points over the past year.
- Aether is more profitable, keeping -227.5 cents of every revenue dollar as net income versus -1741.0 cents for Firefly Neuroscience.
- Firefly Neuroscience grew revenue faster in its latest fiscal year (+957.41% vs -4.11%).
About Firefly Neuroscience
AIFF stock →Firefly Neuroscience, Inc., an artificial intelligence company, develops, markets, and distributes medical devices and technologies that allow high-resolution visualization and evaluation of the complex neurophysiological interconnections of the human brain in North America. The company offers the Evoke System, a system used to perform electroencephalographic (EEG) and event-related potential (ERP) assessments, which are analyzed by its cloud-based platform and returned as structured reports designed to support clinical decision-making for various diseases, including depression, anxiety, ADHD, PTSD, MCI, dementia, Parkinson's disease, bipolar disorder, schizophrenia, schizoaffective disorder, ASD, and traumatic brain injury.
Technology · Computer Software: Prepackaged Software · 17 employees
About Aether
ATHR stock →Aether Holdings, Inc. develops and operates financial technology platform in the United States.
Technology · Computer Software: Prepackaged Software · 7 employees
AIFF vs ATHR FAQ
Which is bigger, Firefly Neuroscience or Aether?
Firefly Neuroscience (AIFF) is larger, with a market capitalization of $11.81M compared with $10.51M for Aether (ATHR).
Which stock has performed better over the past year, AIFF or ATHR?
AIFF returned -52.53% over the past 12 months, compared with -84.55% for ATHR (price return, excluding dividends). Past performance does not predict future results.
Are Firefly Neuroscience and Aether in the same industry?
Yes. Both are classified in the Computer Software: Prepackaged Software industry within the Technology sector.